Company Active LTD

Company profile

Biosceptre (UK) Limited

UK company 08365743, incorporated on 18 January 2013.

Biosceptre Promise beyond cancer

Biosceptre (UK) Limited is a UK company with status Active founded in 2013 based in East of England.

Company number
08365743
Incorporated
18 Jan 2013
Companies House status
Active

Company identity

Founded / incorporated
18 January 2013

Company number 08365743

Verify at Companies House
Legal name
BIOSCEPTRE (UK) LIMITED
Company type
Private Limited Company
Region
East of England
Registered address
SALISBURY HOUSE
STATION ROAD
CAMBRIDGE
UNITED KINGDOM
CB1 2LA
Insolvency history
No

Corporate ownership

Updated 07 Jul 2026 09:49

1 level 1 ultimate controller Controls 6
1
Company Active LTD
Biosceptre (UK) Limited
CRN 08365743
2
Direct and ultimate controller Active LTD

Company events

Reference milestones and recent Companies House filing stream events.

5 events
31 Mar
2027

Accounts due

Accounts Due

Next accounts due date

01 Feb
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

18 Jan
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

30 Jun
2025

Accounts filed

Accounts

Last accounts made up date

18 Jan
2013

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards
First funded
2014
Funded years
2014, 2016
Age at first award
1 years

Projects

2016 GRD Proof of Concept Lead participant

Proof of concept for nf-P2X7 to treat and diagnose cancers

1 Mar 2016 to 30 Sep 2017

Awarded
£99,592
Total cost £165,987

This project will deliver proof of concept (POC) data to identify a new diagnostic and to establish Kidney and lung cancer as therapeutic targets for BIL03s, our lead fully human therapeutic antibody. The World Health Organization reported that 8.2 million died of cancer in 2012. While progress has been made, patient outcomes remain poor particularly for ...

2014 Feasibility Studies Lead participant

Novel therapeutic antibodies against nf-P2X7

1 Jul 2014 to 30 Jun 2015

Awarded
£149,985
Total cost £199,984

In December 2013 the World Health Organization, released data showing that globally there were 14.1 million new cases of cancer and 8.2 million cancer deaths in 2012. Significant medical progress has been made, but patient outcomes remain poor, new cancer cases are increasing and for certain types of cancer, existing treatment options and those in develop...

Product types

Feasibility Studies GRD Proof of Concept